Navigation Links
Computers help chemists fight emerging infections

BOSTON, Aug. 19, 2007 Computer analysis of existing drugs may be key to fighting new infectious agents and antibiotic-resistant pathogens like deadly tuberculosis strains and staph superbugs. Researchers in Canada say the use of such emergency discovery technology could save time, money and lives during a sudden outbreak or a bioterrorism attack. They reported here today at the 234th national meeting of the American Chemical Society.

Drug repurposing or reprofiling is not new: Pharmaceutical companies have been seeking new uses of old drugs to extend patent protections and whenever new, off-label uses of the drugs are found. But reprofiling to deliberately develop emergency drugs is a new concept, made possible by advances in chemoinformatics, a new field that merges chemistry with computer science, according to study presenter Artem Cherkasov, Ph.D., of the University of British Columbia in Vancouver, Canada.

In the case of new infectious threats, there might be no time to develop a completely new drug from the ground up, as the corresponding toxicological studies and regulatory investigations will take years to complete properly, says Cherkasov, a chemist with a background in computer-aided drug design and infectious disease. Finding an already existing, well-studied therapeutic agent that will kill an emerging bug might provide a rapid, first line of defense response option.

Under the new computer-aided system, the researchers plan to first identify vulnerable cellular components of a pathogen using proteomics, or the study of proteins and their interactions. They will enter these key structures into the computer and, using elements of modern Artificial Intelligence, will identify drugs that have the highest potential for activity against the target and for antimicrobial activity, says Cherkasov. Those compounds with the highest ranking can then be quickly tested in the laboratory against the pathogen and eventually used to treat infected individuals, the researcher says.

The new approach is still in development for possible future use during an actual outbreak, Cherkasov notes. However, many non-antibiotic drugs have been shown to have antibiotic-like properties using this technique, he says. For example, computer studies have suggested that lovastatin, a drug marketed to lower cholesterol, and gentisic acid, an anti-inflammatory drug related to aspirin, both show promise as strong antibiotics. But more studies are needed before these compounds can be recommended for use as antibiotics in a clinical setting, he adds.

It is not totally unexpected as there are thousands of existing drugs that are already enriched with target-binding structural features, Cherkasov says. Many of them were not designed as antibiotics but have the potential to act as such.

The chemical structures of compounds we identify usually look nothing like known antibiotics. But if a compound behaves like antibiotic in a computational model, it may act as one in a real life, says Cherkasov, who has programmed his computer system to identify antibiotic likeness, or those chemical structures which have the most potential for antibiotic activity.

There is a growing need to expand and complement the range of available antimicrobial compounds, as many big pharmaceutical companies have withdrawn from the field of anti-infective agents, according to Cherkasov. Only two novel antibiotics have entered the market in the last 20 years, he says.

The researchers plan to soon begin testing some of the newly identified antibiotic candidates against methicillin-resistant Staphylococcus aureus (MRSA). Also known as superbugs, these bacteria are an increasingly worrisome cause of serious hospital-based infections and infections acquired in community settings.

Although Cherkasovs research team specializes in battling bacterial infections, similar techniques can be applied to emerging viral infections, such as SARS and bird flu, he says. Likewise, the technique also provides a potential means of identifying quick treatments for bioterrorism agents, such as new strains of anthrax, as well as rare infectious diseases such as those sometimes encountered in third-world countries.


Contact: Michael Bernstein
American Chemical Society

Related medicine news :

1. Computers may become surgeons
2. Risk of DVT for those spending long hours in front of computers
3. Elderly People Can Take Up Computers To Fight Depression
4. Computers Can Teach Patients About Screening for Cancer
5. From Computers to Vaccines
6. Supercomputers To Assist In Thwarting Bird Flu Epidemic In Future
7. Computers Aid in the Development of Bird Flu Vaccine
8. Dispensing Drug Dosage To Children Through Computers
9. Better Communication Ensured Between Humans and Computers
10. Sleeping Computers Yield Clues About Genetic Disorders
11. Computers Assist Breast Cancer Screening
Post Your Comments:
(Date:10/13/2015)... , ... October 13, 2015 , ... Local Gold’s Gym ... Gym International Conference on August 26. Berry, who owns and operates Gold's Gym ... the fastest growing Gold’s Gyms in the United States. A brand leader in global ...
(Date:10/13/2015)... ... October 13, 2015 , ... Breathing is one of the ... correctly. According to T’ai Chi (also spelled “Taiji”) and Qigong Grand-masters Steven Aung, ... concert with the 7,000 year old tradition they teach, can improve health, increase ...
(Date:10/13/2015)... ... ... With Fall weather approaching and holiday travel season upon us, is giving away ... to win! , How to Enter:, 1. Like on Facebook , 2. ... us on Instagram @thebeautyplace , 4. Share Facebook Contest Image With Friends , ...
(Date:10/13/2015)... DALLAS, Texas (PRWEB) , ... October 13, 2015 ... ... comprehensive treatment possible for children with autism, PediaPlex , a Southlake, Texas, ... value of ABA Therapy and educating military families about their options ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... sustainable and eco-friendly home furnishings and décor, today announced it closed on a ... investor. The funds will be used to support the Company’s continued rapid growth ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... MUNICH , October 13, 2015 ... --> World Thrombosis Day Interactive Infographic   ... World Thrombosis Day  to promote vital ... and signs and symptoms. Thrombosis is the formation ... (venous thrombosis) - resulting in venous thromboembolism (VTE) ...
(Date:10/13/2015)... PARK, Calif. , Oct. 13, 2015 /PRNewswire/ ... an agreement with the UK-based Cell Therapy Catapult ... for AST-VAC2, Asterias, allogeneic dendritic cell immunotherapy. Under ... and scale manufacturing processes for AST-VAC2 to support ... --> --> ...
(Date:10/12/2015)... -- Given the intricacy of the anatomy and ... an ophthalmic drug effectively to a specific ocular site. Several ... delivery. These include dilution of a drug by tears, clearance ... drug permeation issues with respect to the cornea, sclera and ... is lost due to the aforementioned barriers. --> ...
Breaking Medicine Technology: